Henry A. Nasrallah

Also affiliated with University of Cincinnati Medical Center

MedicineArts and HumanitiesNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial”.

Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial

UNC Libraries(2020)10.17615/bpkg-gc25

N/A

0DataRank · unranked

0 citations

Ira D. Glick, Joseph P. McEvoy, Neepa Ray, Ahsan Y. Khan, Robert M. Hamer +5 more

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I

Journal of Clinical Psychopharmacology(2025)10.1097/jcp.0000000000001987

N/A

0DataRank · unranked

28 citations

Ross J. Baldessarini, Richard Balon, John Bilbily, Stanley N. Caroff, Leslie Citrome +35 more

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II

Journal of Clinical Psychopharmacology(2025)10.1097/jcp.0000000000001990

N/A

0DataRank · unranked

28 citations

Ross J. Baldessarini, Richard Balon, John Bilbily, Stanley N. Caroff, Leslie Citrome +35 more